Today on Ask an Expert, we are taking a closer look at the treatment that has recently been approved by the FDA, for people living with early Alzheimer's.
 
The treatment, called Kisunla, is designed to slow the progression of early symptomatic Alzheimer's disease. The approval from the food and drug administration has brought hope to many people, who are wondering when and how they can receive the treatment. 

To answer those questions and more KCBS Radio's Eric Thomas spoke with Claire Day, Interim Executive Director at the Alzheimer's Association.